Matthew R Vogt

Univ Of North Carolina Chapel Hill

$8,850,820

Attributed

$8,850,820

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $6.2M · FY2021–25

$10M$7.5M$5M$2.5M$0

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$8,850,820 · 3

By mechanism

U19$5,421,688 · 1

R01$2,528,960 · 1

K08$900,172 · 1

Top collaborators

No co-investigators on record.

Most similar at Univ Of North Carolina Chapel Hill

Same institution · by research overlap

Craig E. Cameron$40,640,525
David A Wohl$27,961,733
William Fischer$5,095,957
Hinh Ly$4,358,390
Vineet D Menachery$15,198,106

Others in their field

Other Emerging Leaders on “Virus”

Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$206,525,404
Leonard Freedman · Leidos Biomedical Research, Inc.$79,828,969
Ted Ross · University Of Georgia$71,962,304
Beth Baseler · Leidos Biomedical Research, Inc.$67,833,289
Tony Moody · Duke University$66,767,417
Matthew Johnson · Duke University$61,899,930

Research focus

VirusAcute Flaccid MyelitisSurfaceVaccinesParalysedPoliomyelitisMonoclonal AntibodiesSerumEnterovirus 68In VivoNeutralizing AntibodyAntibody ResponseHuman Monoclonal AntibodiesB-LymphocytesChildInfectionPolyclonal AntibodyResponseCell Culture TechniquesEnterovirusAntibodiesEpitopesHuman PoliovirusEpithelial Cells